Mesoblast Limited (ASX:MSB)
2.035
-0.015 (-0.73%)
Aug 3, 2026, 12:52 PM AEST
Mesoblast Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Mesoblast stock has a consensus rating of "Strong Buy" and an average price target of $3.85. The average 1-year stock price forecast is 89.19% higher than the current stock price, while the lowest is $3.00 (+47.42%) and the highest is $4.71 (+131.45%).
Price Target: $3.85 (+89.19%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Mesoblast stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bell Potter | Bell Potter | Buy Upgrades $4.45 | Buy | Upgrades | $4.45 | +118.67% | Jul 12, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $3.23 | Buy | Maintains | $3.23 | +58.72% | Jul 9, 2026 |
| Jefferies | Jefferies | Buy Maintains $2.80 | Buy | Maintains | $2.80 | +37.59% | Apr 9, 2026 |
Financial Forecast
Revenue This Year
117.54M
from 17.20M
Increased by 583.48%
Revenue Next Year
202.95M
from 117.54M
Increased by 72.66%
EPS This Year
-0.04
from -0.07
EPS Next Year
0.03
from -0.04
EPS and Forward PE are based on non-GAAP adjusted numbers.